Marine Biomedical's PearlBone gains FDA clearance for US bone repair market
Marine Biomedical's PearlBone, a bone graft substitute made from Kimberley pearl shells, received FDA clearance for the US market. The bone repair product is the first of its kind using nacre, valued at $1.1 billion in the US. Although regulatory approval is a significant milestone, further steps are needed before it can be marketed to patients.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 14 Nov 2026, 02:06 UTC · Updated 14 Nov 2026, 02:10 UTC
Summary by OZbrief Editorial. Original report: ABC News – Australia. Editorial policy · Corrections
Trending
- Melbourne art teacher Alice Krause apologizes after racist car park outburst
- Pino, the autonomous kiwi, demonstrates AI's human-like curiosity and creativity
- Advance Metals, Sky Metals launch $6M IPO for new gold company
- Opera Queensland's Into the Woods opened at Glasshouse Theatre with standout cast
- Police raid $18 million Brighton mansion linked to bikie president Balsillie
- Police investigate break-in at Chris Hemsworth’s home; three vehicles stolen